STSSW — SkyAI, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1737995 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 192,780 -9,798 -4,566,106 -86,239,232 181,002,610 12,320,547 2,219,220
Dec 2025 -102,224 1,788,358 102,382,029 -182,656,973 269,075,173 10,382,745 4,695,027
Sep 2025 83,622 -1,169,656 -110,646,359 -105,333,293 443,960,043 10,521,706 10,745,886
Jun 2025 222,722 -1,032,027 -3,006,382 3,559,307 17,085,197 8,322,192 2,545,527

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-12,250,082
Investing CF
$-178,234,025
Financing CF
$196,882,955
CapEx
$-189,575,170
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-403,186,564
Inventory
$457,709
Receivables
$718,471
ST Investments
EBIT TTM
$-272,463,114
Pretax Income TTM
$-358,503,501
Interest Exp TTM
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,531,009
EBITDA
$-16,394,520
Free Cash Flow
$89,307,704
Enterprise Value
Total Cash
$12,320,547
Total Debt
$0
Shares Out
Trailing EPS
$-0.96
Book Value
$4.54
ROE
-380.3%
ROA
-10.3%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 204,120 -13,292,480 -282,502,126 269,075,173 4,695,027 -10,990,651
Dec 2024 0 -5,567,599 -9,296,201 7,313,748 5,317,619 -4,401,392
Dec 2023 0 -10,126,650 -9,841,638 11,789,268 3,854,982 -8,507,300
Dec 2022 0 -8,738,793 -4,639,662 11,839,656 2,198,522 -6,433,159

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $144.07B $406.78
SYK STRYKER CORP $115.45B $301.14
MDT Medtronic plc $101.56B $79.34
MMM 3M CO $83.05B $159.23
BSX BOSTON SCIENTIFIC CORP $67.32B $45.29

News headlines (Yahoo Finance, 1h cache)

From MedTech to SOL Machine: Why Sharps Technology Just Landed on Crypto Radar
2026-04-06 19:10 · Yahoo
Can Coinbase (COIN) Leverage Growing Institutional SOL Demand to Strengthen Its Crypto Custody Edge?
2025-10-12 01:07 · Yahoo
Sharps Technology Moves $435M Solana Treasury to Coinbase — Will It Top Rivals?
2025-10-09 21:30 · Yahoo
Nasdaq-Listed Solana Company Grows Treasury to $525M in SOL Holdings – Solana About to Explode?
2025-10-07 10:33 · Yahoo
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
2025-10-07 03:51 · Yahoo
Sharps Technology Unveils $100M Solana Buyback – Are Treasury Firms Turning Sour on SOL?
2025-10-02 20:51 · Yahoo
Sharps Technology Teams Up With Crypto.com To Grow Solana Strategy
2025-10-02 13:26 · Yahoo
Sharps Technology Announces $100 Million Stock Repurchase Program
2025-10-02 11:00 · Yahoo
Sharps Technology Bets Big On Solana With New DeFi Partnership
2025-09-23 12:43 · Yahoo
This Digital Asset Treasury Stock Is Betting Big on the BONK Meme Crypto. Should You Buy Its Shares Here?
2025-09-22 15:42 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.